Powderly WG - Search Results

1

Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis.

Sungkanuparph S, Overton ET, Seyfried W, Groger RK, Fraser VJ, Powderly WG. Sungkanuparph S, et al. Among authors: powderly wg. Clin Infect Dis. 2005 Nov 1;41(9):1326-32. doi: 10.1086/496985. Epub 2005 Sep 29. Clin Infect Dis. 2005. PMID: 16206110

2

Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants.

Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG. Bailey TC, et al. Among authors: powderly wg. J Infect Dis. 1992 Mar;165(3):548-52. doi: 10.1093/infdis/165.3.548. J Infect Dis. 1992. PMID: 1311352 Clinical Trial.

3

Therapy for cryptococcal meningitis in patients with AIDS.

Powderly WG. Powderly WG. Clin Infect Dis. 1992 Mar;14 Suppl 1:S54-9. doi: 10.1093/clinids/14.supplement_1.s54. Clin Infect Dis. 1992. PMID: 1562696 Review.

4

Blastomycosis in patients with the acquired immunodeficiency syndrome.

Pappas PG, Pottage JC, Powderly WG, Fraser VJ, Stratton CW, McKenzie S, Tapper ML, Chmel H, Bonebrake FC, Blum R, et al. Pappas PG, et al. Among authors: powderly wg. Ann Intern Med. 1992 May 15;116(10):847-53. doi: 10.7326/0003-4819-116-10-847. Ann Intern Med. 1992. PMID: 1567099

5

Two cases of blastomycosis from a common source: use of DNA restriction analysis to identify strains.

Fraser VJ, Keath EJ, Powderly WG. Fraser VJ, et al. Among authors: powderly wg. J Infect Dis. 1991 Jun;163(6):1378-81. doi: 10.1093/infdis/163.6.1378. J Infect Dis. 1991. PMID: 1674750

6

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

Reichman RC, Morse GD, Demeter LM, Resnick L, Bassiakos Y, Fischl M, Para M, Powderly W, Leedom J, Greisberger C, et al. Reichman RC, et al. J Infect Dis. 1995 Feb;171(2):297-304. doi: 10.1093/infdis/171.2.297. J Infect Dis. 1995. PMID: 7531207 Clinical Trial.

7

Risks of HIV infection in the health care setting.

Fraser VJ, Powderly WG. Fraser VJ, et al. Among authors: powderly wg. Annu Rev Med. 1995;46:203-11. doi: 10.1146/annurev.med.46.1.203. Annu Rev Med. 1995. PMID: 7598457 Review.

8

Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study.

Fichtenbaum CJ, Woeltje KF, Powderly WG. Fichtenbaum CJ, et al. Among authors: powderly wg. Clin Infect Dis. 1994 Sep;19(3):417-22. doi: 10.1093/clinids/19.3.417. Clin Infect Dis. 1994. PMID: 7811859

9

Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.

Powderly WG, Cloud GA, Dismukes WE, Saag MS. Powderly WG, et al. Clin Infect Dis. 1994 May;18(5):789-92. doi: 10.1093/clinids/18.5.789. Clin Infect Dis. 1994. PMID: 8075272 Clinical Trial.

10

Cryptococcal meningitis and AIDS.

Powderly WG. Powderly WG. Clin Infect Dis. 1993 Nov;17(5):837-42. doi: 10.1093/clinids/17.5.837. Clin Infect Dis. 1993. PMID: 8286622 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters